A sensitive method for continuously monitoring the activity of the human cytosolic phospholipase \(A_{2}\) \(\left(\mathrm{cPLA}_{2}\right)\) ) is described. Recombinant cPLA \(\mathbf{A}_{2}\) efficiently hydrolyzes fatty acid esters of 7 -hydroxycoumarin, producing the free fatty acid and the high
A Fluorescence-Based Assay for Human Type II Phospholipase A2
β Scribed by S.G. Blanchard; C.O. Harris; D.J. Parks
- Book ID
- 102966276
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 527 KB
- Volume
- 222
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
β¦ Synopsis
A fluorescence assay for quantitation of human Type II Phospholipase (A_{2}) activity is described. Hydrolysis of 1-Acyl-2-(N-4-nitrobenzo-2-oxo-1,3-diazole)aminododecanoyl Phosphatidylethanolamine is accompanied by an increase in fluorescence intensity that is linearly proportional to enzyme activity. Substrate is prepared in the absence of detergents as a sonicated dispersion in aqueous buffer. Hydrolysis of the corresponding phosphatidylcholine derivative is more than an order of magnitude slower under identical assay conditions. A plot of initial rate versus substrate concentration could be fit to a simple Michaelis-Menten relationship with (K_{m}=13 \mu \mathrm{M}). In contrast to commonly used radiochemical assays for this enzyme, the method described here is continuous and allows estimation of enzyme activity without separation of substrate from product. Thus, the method is suitable for both kinetic analysis and largescale screening using automated readers for 96 -well tissue culture plates. The fluorescence-based assay displays advantages over other continuous assays for human Type II Phospholipase (A_{2}) based on (a) high sensitivity and (b) the use of a commercially available substrate. 1994 Academic Press, Inc.
π SIMILAR VOLUMES
Melittin and phospholipase A 2 -activating protein (PLAP) are known as efficient activators of secretory phospholipase A 2 (sPLA 2 ) types I, II, and III when phospholipid liposomes are used as substrate. The present study demonstrates that both peptides can either inhibit or activate sPLA 2 dependi